Kotemul, K., Pata, S., Laopajon, W., Kasinrerk, W. and Takheaw, N. 2024. A genetically engineered mouse/human chimeric antibody targeting CD99 enhances antibody-dependent cellular phagocytosis against human mantle cell lymphoma Z138 cells. Journal of Associated Medical Sciences. 57, 3 (Jun. 2024), 52–64.